Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form SC 13G
Source: SEC/Edgar
January 07, 2010
Form 6-K
Source: SEC/Edgar
January 04, 2010
Form 6-K
Source: SEC/Edgar
January 03, 2010
Form 6-K
Source: SEC/Edgar
December 21, 2009
Form 6-K
Source: SEC/Edgar
December 14, 2009
Form 6-K
Source: SEC/Edgar
December 07, 2009
Form 6-K
Source: SEC/Edgar
December 01, 2009
Form 6-K
Source: SEC/Edgar
November 29, 2009
Form 6-K
Source: SEC/Edgar
November 23, 2009
Form 6-K
Source: SEC/Edgar
November 16, 2009
Form 6-K
Source: SEC/Edgar
November 08, 2009
Form 6-K
Source: SEC/Edgar
November 08, 2009
Form 6-K
Source: SEC/Edgar
November 03, 2009
Form 6-K
Source: SEC/Edgar
November 02, 2009
Form 6-K
Source: SEC/Edgar
October 29, 2009
Form 6-K
Source: SEC/Edgar
October 25, 2009
Form 6-K
Source: SEC/Edgar
October 18, 2009
Form 11-K
Source: SEC/Edgar
October 18, 2009
Form 11-K
Source: SEC/Edgar
October 07, 2009
Form 6-K
Source: SEC/Edgar
October 05, 2009
Form 6-K
Source: SEC/Edgar
October 01, 2009
Form 6-K
Source: SEC/Edgar
September 28, 2009
Form 6-K
Source: SEC/Edgar
September 22, 2009
Form 6-K
Source: SEC/Edgar
September 20, 2009
Form 6-K
Source: SEC/Edgar
September 14, 2009
Form 6-K
Source: SEC/Edgar
September 07, 2009
Form 6-K
Source: SEC/Edgar
August 31, 2009
Form 6-K
Source: SEC/Edgar
August 23, 2009
Form 6-K
Source: SEC/Edgar
August 17, 2009
Form 6-K
Source: SEC/Edgar
August 10, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.